Immunohistochemical analysis of 11-β-hydroxysteroid dehydrogenase type 2 and glucocorticoid receptor in subclinical cushing's disease due to pituitary macroadenoma

Endocrine Pathology

Volumn 19, Issue 4, 2008, Pages 252-260

  Ebisawa, Takanori ^a   Tojo, Katsuyoshi ^a   Tajima, Naoko ^a   Kamio, Masami ^a   Oki, Yutaka ^b   Ono, Katsuhiko ^c   Sasano, Hironobu ^c  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

11 hydroxysteroid dehydrogenase type 2; ACTH; Glucocorticoid receptor; Immunohistochemistry; Pituitary macroadenoma; Subclinical Cushing's disease

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; CORTICOTROPIN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR;

ACROMEGALY; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CUSHING DISEASE; CUSHINGOID SYNDROME; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS MACROADENOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROADENOMA; PRIORITY JOURNAL; ACTH SECRETING ADENOMA; ADENOMA; ADOLESCENT; HYPOPHYSIS; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ACROMEGALY; ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PITUITARY ACTH HYPERSECRETION; PITUITARY GLAND; RECEPTORS, GLUCOCORTICOID; YOUNG ADULT;

EID: 60749134251     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12022-008-9052-0     Document Type: Article

References (29)

1. PL Dahia AB Grossman 1999 The molecular pathogenesis of corticotroph tumors Endocr Rev. 20 136 155
2. SWJ Lamberts 2002 Glucocrticoid receptors and Cushing's disease Mol Cell Endocrinol. 197 69 72
3. J Drouin J Charron JP Gagner L Jeannotte M Nemer RK Plante O Wrange 1987 Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids J Cell Biochem. 35 293 304
4. J Drouin S Bilodeau S Vallette 2007 Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency Clin Genet. 72 175 182
5. M Ruiz U Lind M Gafvels G Eggertsen J Carlstedt-Duke L Nilsson M Holtmann P Stierna A Wilkstrom S Werner 2001 Characterization of two novel mutations in the glucocrticoid receptor gene in patients with primary cortisol resistance Clin Endocrinol. 55 363 371
6. M Karl SW Lamberts JW Koper DA Katz NE Huizenga T Kino BR Haddad MR Hudhes GP Chrousos 1996 Cushing's disease preceded by generalized glucocorticoid resistance: clinical consequence of a novel, dominant-negative glucocorticoid receptor mutation Proc Assoc Am Physicians 108 296 307
7. M Karl GV Wichert E Kempter DA Katz M Reincke H Monig IU Ali CA Stratakis EH Oldfield GP Chrousos HM Schulte 1996 Nelson's syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene J Clin Endocrinol Metab. 81 124 129
8. G Assie H Bahurel J Coste S Silvera M Kujas MA Dugue F Karray B Dousset J Bertherat P Legmann X Bertagna 2007 Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome J Clin Endocrinol Metab. 92 172 179
9. MD Woods MJ Shipston EL Mullens FA Antoni 1992 Pituitary corticotrope tumor (AtT20) cells as a model system for the study of early inhibition by glucocorticoids Endocrinology. 131 2873 2880
10. L Katznelson JS Bogan JR Trob DA Schoenfeld ET Hedley-Whyte DW Hsu NT Zervas B Swearingen M Sleeper A Klibanski 1998 Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas J Clin Endocrinol Metab. 83 1619 1623
11. M Korbonits I Bujalska M Shimojo J Nobes S Jordan AB Grossman PM Stewart 2001 Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors J Clin Endocrinol Metab. 86 2728 2733
12. EH Rabbitt J Ayuk K Boelaert MC Sheppard M Hewison PM Stewart NJ Gittoes 2003 Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation Oncogene. 22 1663 1667
13. N Draper PM Stewart 2005 11 β-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action J Endocrinol. 186 251 271
14. T Nigawara Y Iwasaki M Asai M Yoshida M Kambayashi H Sashinami K Hashimoto T Suda 2006 Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells Endocrinology. 147 769 772
15. T Takao T Mimoto M Yamamoto K Hshimoto 2001 Preclinical Cushing's disease Arch Intern Med. 161 892 893
16. T Nagai M Imamura S Misumi M Mori 2002 Subclinical Cushing's disease accompanied by malignant hypertension and diabetes mellitus Intern Med. 41 566 570
17. K Kageyama T Moriyama S Sakihara S Kawashima T Suda 2003 A case of preclinical Cushing's disease, accompanied with thyroid papillary carcinoma and adrenal incidentaloma Endocr J. 50 325 331
18. S Cannavo B Almoto CD Asta S Corsello RM Lovicu ED Menis F Trimarchi B Ambrosi 2003 Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas Eur J Endocrinol. 149 195 200
19. YS Woo AM Ishidori WZ Wat GA Kaltsas F Afshar I Sabin PJ Jenkins JP Monson GM Besser AB Grossman 2005 Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas J Clin Endocrinol Metab. 90 4963 4969
20. HS Kooistra G Voorhout JA Mol A Rijinberk 1997 Correlation between impairment of glucocorticoid feedback and the size of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism J Endocrinol. 152 387 394
21. JT Bosje A Rijinberk JA Mol G Voorhout HS Kooistra 2002 Plasma concentration of ACTH precursors correlate with pituitary size and resistance to dexamethasone in dogs with pituitary-dependent hyperadrenocorticism Domest Anim Endocrinol. 22 201 210
22. T Suzuki H Sasano S Suzuki G Hirasawa J Takeyama Y Muramatsu F Date H Nagura ZS Krozowski 1998 11 β-Hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action J Clin Endocrinol Metab. 83 4022 4025
23. ZS Krozowski JA Maguire AN Stein-Oakley J Dowling RE Smith RK Andrews 1995 Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta J Clin Endocrinol Metab. 80 2203 2209
24. S Gibson DW Ray SR Crosby TL Dornan AM Jennings JS Bevan JRE Davis A White 1996 Impaired processing of pro-opiomelanocortin in invasive corticotroph adenomas J Clin Endocrinol Metab. 81 497 502
25. S Gibson SR Crosby MF Stewart E McCall A White 1994 Differential release of pro-opiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays J Clin Endocrinol Metab. 78 835 841
26. NATM Huizenga P Lange JW Koper RN Clayton WE Farreli AJ Lely AO Brinkmann FH Jong SWJ Lamberts 1998 Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucoocrticoid receptor gene locus J Clin Endocrinol Metab. 83 917 921
27. YM Mu R Tkayanagi K Imasaki K Ohe S Ikuyama T Ynase H Nawata 1998 Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test Clin Endocrinol. 49 301 306
28. T Okabe R Takayanagi M Adachi K Imasaki H Nawata 1998 Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells J Endocrinol. 156 169 175
29. C Martens S Bilodeau M Maira Y Gauthier J Drouin 2005 Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor Mol Endocrinol. 19 885 897